Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Katholieke Universiteit Leuven K u leuven R & d patents


Recent patent applications related to Katholieke Universiteit Leuven K u leuven R & d. Katholieke Universiteit Leuven K u leuven R & d is listed as an Agent/Assignee. Note: Katholieke Universiteit Leuven K u leuven R & d may have other listings under different names/spellings. We're not affiliated with Katholieke Universiteit Leuven K u leuven R & d, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "K" | Katholieke Universiteit Leuven K u leuven R & d-related inventors


Patterning device

A novel miniaturized and highly automated method for the controlled printing of large arrays of nano- to femtoliter droplets is presented by actively transporting mother droplets over hydrophilic-in-hydrophobic micropatches. The proposed technology consists of single plate or double-plate devices where mother droplets can be actuated and hydrophilic-in-hydrophobic micropatches on one... Katholieke Universiteit Leuven K u leuven R & d

Means and methods for treatment of early-onset parkinson's disease

This application relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular, the disclosure describes that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular, the treatment of patients suffering from Parkinson's disease having loss of function mutations... Katholieke Universiteit Leuven K u leuven R & d

Direct and selective inhibition of mdm4 for treatment of cancer

The present application relates to the field of cancer, particularly that of cancers with high MDM4 protein levels (such as melanoma, breast, colon or lung cancers, glioblastoma, retinoblastoma, etc.). It is shown herein that direct and selective inhibition of MDM4, e.g., by antisense RNA, leads to growth inhibition of cancer... Katholieke Universiteit Leuven K u leuven R & d

System for interpretation of image patterns in terms of anatomical or curated patterns

Imaging mass spectrometry (IMS) has become a prime tool for studying the distribution of biomolecules in tissue. Although IMS data sets can become very large, computational methods have made it practically feasible to search these experiments for relevant findings. However, these methods lack access to an important source of information... Katholieke Universiteit Leuven K u leuven R & d

Fused bicyclic heteroaromatic derivatives as kinase inhibitors

A series of fused bicyclic heteroaromatic derivatives of formula (IA) or (IB), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.... Katholieke Universiteit Leuven K u leuven R & d

Pyrazolo-pyridine derivatives as kinase inhibitors

A series of pyrazolo[3,4-b]pyridine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and... Katholieke Universiteit Leuven K u leuven R & d

Fused bicyclic heteroaromatic derivatives as kinase inhibitors

A series of fused bicyclic heteroaromatic derivatives of formula (I), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.... Katholieke Universiteit Leuven K u leuven R & d

Inhibition of neat1 for treatment of solid tumors

The application relates to the field of cancer, particularly to the field of solid tumors. It was found that a particular long non-coding RNA (lncRNA), NEAT1, an essential architectural component of nuclear paraspeckles, is required for the survival of cancer, but not that of normal, non-transformed, cells. Inhibition of NEAT1... Katholieke Universiteit Leuven K u leuven R & d








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Katholieke Universiteit Leuven K u leuven R & d in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Katholieke Universiteit Leuven K u leuven R & d with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###